title: Angioedema during therapy with recombinant tissue plasminogen activator.
authors.affiliation: Department of Medicine, University of Rochester, School of Medicine and Dentistry, New York.
authors.forename: C W
authors.initials: CW
authors.lastname: Francis
authors.forename: B
authors.initials: B
authors.lastname: Brenner
authors.forename: J P
authors.initials: JP
authors.lastname: Leddy
authors.forename: V J
authors.initials: VJ
authors.lastname: Marder
mesh_terms: D000799:Angioedema / Q000139:chemically induced* / Q000276:immunology; D003167:Complement Activation / Q000502:physiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator